Global gene panel market 2024-2028

Global Gene Panel Market 2024-2028

The gene panel market is forecasted to grow by USD 5403.9 mn during 2023-2028, accelerating at a CAGR of 23.44% during the forecast period. The report on the gene panel market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of gene panels in cancer-targeted therapies, increasing number of people with genetic disorders, and decreasing cost of next generation sequencing (NGS) gene panel tests.

Technavio's gene panel market is segmented as below:

By Product

• Small panel testing
• Large panel testing

By Technique

• Amplicon
• Hybridization

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the collaboration to maximize research efficiency as one of the prime reasons driving the gene panel market growth during the next few years. Also, availability of over the counter test and increasing use of gene panels to identify potential side effects in patients will lead to sizable demand in the market.

The report on the gene panel market covers the following areas:

• Gene panel market sizing
• Gene panel market forecast
• Gene panel market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene panel market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fagron NV, GenXPro GmbH, Illumina Inc., Invitae Corp., MedGenome Labs Ltd., MGZ Medizinisch Genetisches Zentrum, Novogene Co. Ltd., OPKO Health Inc., Oxford Nanopore Technologies plc, QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.. Also, the gene panel market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.